Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Total Non-Current Liabilities (2013 - 2026)

Updated

Grace Therapeutics (GRCE) posted Total Non-Current Liabilities of $2.76 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 35.0% from $4.24 million a year earlier and down 23.3% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Since fiscal Q4 2013, Grace Therapeutics has reported Total Non-Current Liabilities for 45 quarters.

  • Annual Total Non-Current Liabilities has declined for four consecutive fiscal years, though with a five-year compound annual growth rate of 11.8% (FY2021 to FY2026).
  • In prior fiscal years, Grace Therapeutics' Total Non-Current Liabilities was $4.24 million in FY2025 (-41.1%), $7.2 million in FY2024 (-35.5%), $11.17 million in FY2023 (-45.1%) and $20.34 million in FY2022.
  • The fiscal Q4 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since fiscal Q1 2022.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last seven quarters, with an average decline of 34.9% over the last seven quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was fiscal Q3 2023, with growth of 593.2%; the weakest was fiscal Q2 2024, with a decline of 61.4%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior fiscal quarters was $3.6 million (Q3 2026), $3.56 million (Q2 2026) and $4.63 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 102.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 117.60 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -36.84 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 96.04 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.76 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 3.56 Mn
Jun 30, 2025 4.63 Mn
Mar 31, 2025 4.24 Mn
Dec 31, 2024 5.30 Mn
Sep 30, 2024 6.61 Mn
Jun 30, 2024 7.39 Mn
Mar 31, 2024 7.20 Mn
Dec 31, 2023 8.17 Mn
Sep 30, 2023 8.01 Mn
Mar 31, 2023 11.17 Mn
Dec 31, 2022 20.08 Mn
Sep 30, 2022 20.75 Mn
Mar 31, 2022 20.34 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 4.48 Mn
Jun 30, 2021 2.35 Mn
Mar 31, 2021 1.58 Mn
Dec 31, 2020 2.25 Mn
API Access

Grace Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY